BST2 and breast cancer: We found BST2, an important bone marrow stromal protein, to be significantly up-regulated in the bone metastatic breast cancer cell line, MDA-231BO, compared to MDA-231 (Expression ratios = 3.2, 4.5, 4.29, 3.97 and 4.9) (Figure 1).